Table 3.
Surgical History, Medical History, and Adjuvant Oncologic Treatment of Included Subjects
| Author | Modality | Single | Previous Abd. Surgery | Smoker | Hypertension | Diabetes | Adj. ChT | RT |
|---|---|---|---|---|---|---|---|---|
| Haddock et al1 | SS | 35 (27%) | 26 (74.3%) | 13 (37.1%) | 15 (42.9%) | 3 (8.6%) | 9 (25.7%) | 13 (18.6%) |
| CoS | 69 (54%) | 56 (81.2%) | 27 (39.1%) | 20 (29%) | 7 (10.1%) | 18 (26.1%) | 35 (25.4%) | |
| Bauermeister et al25 | SS | 27 (54%) | 16 (59%) | 1 (4%) | 7 (26%) | 4 (15%) | 22 (81%) | 6 (22%) |
| CoS | 23 (46%) | 15 (65%) | 2 (9%) | 6 (26%) | 3 (13%) | 17 (74%) | 3 (13%) | |
| Gösseringer et al26 | SS | 16 (16%) | —— | 0 (0%) | — | — | — | 10 (62.5%) |
| CoS | 64 (64%) | — | 1 (1.6%) | — | — | — | 45 (70.3%) | |
| Razdan et al27 | SS | 80 (59%) | — | 0 (0%) | — | — | — | 29 (18.1%) |
| CoS | 56 (41%) | — | 1 (1.8%) | — | — | — | 17 (15.2%) | |
| Weichman et al28 | SS | 54 (34.4%) | — | 0 (0%) | — | — | — | — |
| CoS | 103 (65.6%) | — | 0 (0%) | — | — | — | — | |
| Asaad et al29 | SS | 1149* (50%) | — | — | 365 (32%) | 94 (8%) | — | 107 (9%) |
| CoS | 1149* (50%) | — | — | 368 (32%) | 100 (9%) | — | 123 (11%) | |
| Mericli et al30 | SS | 50* (50%) | — | 1.7% | 4.6% | 6.6% | — | 38.6% |
| CoS | 50* (50%) | — | 2% | 4.5% | 7.2% | — | 39.4% |
*
After propensity score matching.
Abd., abdominal; Adj, adjuvant; ChT, chemotherapy; RT, radiotherapy.